Top Growth Stocks - Invest Million

Acceleron Pharma (NASDAQ: XLRN) Rockets On Successful Phase 2 Study For PAH Treatment

Acceleron Pharma Inc (NASDAQ: XLRN) was a top gainer in yesterday’s trading session, and closed the day with gains of 50.16%. This followed the company’s announcement that, its mid-stage study for Sotatercept, its treatment candidate for people with PAH (Pulmonary Arterial

Financial

Small Cap Stock, Tetraphase Pharmaceuticals (NASDAQ: TTPH), Rallies After Earnings and Ratings

Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) was one of the top gainers in yesterday’s trading session. The stock rallied by 50% to close the day at $3.60. This followed a positive rating by 10 rating firms. Seven of them had a consensus of,

NASDAQ: ONCY

Oncolytics Biotech (NASDAQ: ONCY) Sustains Gains Days After Positive News on Pelareorep, a Treatment For Solid Tumors

Oncolytics Biotech Inc (NASDAQ: ONCY) was a big gainer in Tuesday’s trading session, and closed the day with gains of 34.33%. This came a few days after the company announced acceptance of an abstract for a potential new biomarker data from the

Financial

Okta Inc (NASDAQ: OKTA) to Present at The 22nd Annual Needham Growth Conference in January 2020

Okta Inc (NASDAQ: OKTA) has been a top performer for the better part of 2019. Looking at its performance in the last 52-weeks, the stock is up 87.34%. A week ago, the company released its Q3 earnings, and they were higher than consensus

Gaining Stocks

Marinus Pharmaceuticals (NASDAQ: MRNS) Rallies After Giving Updates for its Clinical Studies and Public Stock Offering

Marinus Pharmaceuticals (NASDAQ: MRNS) was one of the top gainers in Wednesday’s trading session, and closed the day with gains of 37.98%. This followed the company’s clinical and regulatory updates for its orphan seizure programs in tuber sclerosis complex (TSC), PCDH-19